06.18.15
Naples, Fla.-based Arthrex Inc. has been ordered to pay $35 million to Californian company KFx Medical in a patent infringement lawsuit. The amount was affirmed by the United States District Court for the Southern District of California. This particular patent is for a system and method for attaching soft tissue to bone.
On Aug. 1, 2011, KFx filed the complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311, which is for a system and method for attaching soft tissue to bone. Previously KFx licensed the ‘311 family of patents to Johnson & Johnson and Smith & Nephew.
In April, the U.S. Court of Appeals reaffirmed their Jan. 20, 2015 ruling upholding a judgment of the United States District Court for the Southern District of California and denied Arthrex’s petition for en banc rehearing and issued a mandate to enforce the judgment.
Separately, Arthrex was also ordered to pay a total of $99 million to British company Smith & Nephew plc, also for a patent infringement. This patent, now expired, pertains to fundamental technology used to implant suture anchors to surgically reattach soft tissue to bone. It is owned by John O. Hayhurst, M.D., of Portland, Ore. and exclusively licensed to Smith & Nephew.
On Aug. 1, 2011, KFx filed the complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311, which is for a system and method for attaching soft tissue to bone. Previously KFx licensed the ‘311 family of patents to Johnson & Johnson and Smith & Nephew.
Arthrex, KFx Medical and Smith & Nephew all make orthopedic surgical products.
On Aug. 1, 2011, KFx filed the complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311, which is for a system and method for attaching soft tissue to bone. Previously KFx licensed the ‘311 family of patents to Johnson & Johnson and Smith & Nephew.
In April, the U.S. Court of Appeals reaffirmed their Jan. 20, 2015 ruling upholding a judgment of the United States District Court for the Southern District of California and denied Arthrex’s petition for en banc rehearing and issued a mandate to enforce the judgment.
Separately, Arthrex was also ordered to pay a total of $99 million to British company Smith & Nephew plc, also for a patent infringement. This patent, now expired, pertains to fundamental technology used to implant suture anchors to surgically reattach soft tissue to bone. It is owned by John O. Hayhurst, M.D., of Portland, Ore. and exclusively licensed to Smith & Nephew.
On Aug. 1, 2011, KFx filed the complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311, which is for a system and method for attaching soft tissue to bone. Previously KFx licensed the ‘311 family of patents to Johnson & Johnson and Smith & Nephew.
Arthrex, KFx Medical and Smith & Nephew all make orthopedic surgical products.